Latest News

PR Newswire

Senhwa Biosciences Secures Strategic Backing from Global Investor GEM with Up to NT$500 Million to Accelerate AI-Driven Drug Development

Apr

14

2026

The Silicon Valley Post

CellType Uses AI to Simulate Human Biology for Drug Discovery

Mar

25

2026

BioSpectrum

Taiwan's Senhwa Biosciences inks immunotherapy deal with US biotech firm CellType

Mar

04

2026

Investors Hangout

Senhwa Biosciences Partners with BeOne for Advanced Cancer Treatment

Dec

11

2025

Yahoo News

Google's AI model identified Silmitasertib (CX-4945) as a potential key to boosting tumor antigen presentation by turning cold tumors to hot ones, a new potential cancer therapy pathway.

Oct

16

2025

PR Newswire

Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today

Jun

25

2025

LABIOTECH

Seven biotech companies keeping Taiwan dynamic in 2025

Mar

07

2025

PennState Health

Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors

Sep

30

2024